Newsletter - All News

Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research

Category
Continent
From
To
 
Neurocrine Bets on CRF Biology for Obesity: First-...

Neurocrine Bets on CRF Biology for Obesity: First-...

Category : Clinical Trial Update 5 May 2026

The obesity drug race just got a new contender—and it’s not another GLP-1 copycat. Ne...
First New Motion Sickness Drug in 40+ Years Hits t...

First New Motion Sickness Drug in 40+ Years Hits t...

Category : Product Related Updates 5 May 2026

For decades, motion sickness treatments barely evolved. That changes now. Vanda Pharmaceuticals has...
UCB Drops $2B on Candid Therapeutics to Double Dow...

UCB Drops $2B on Candid Therapeutics to Double Dow...

Category : Merger/Acquisition 5 May 2026

This isn’t a small bolt-on deal. It’s a platform bet. UCB has signed a definitive agreem...
VOXZOGO Strengthens Its Position in Achondroplasia...

VOXZOGO Strengthens Its Position in Achondroplasia...

Category : Clinical Trial Update 4 May 2026

For years, treating Achondroplasia meant managing complications—not changing the disease traje...
Everads Pushes Suprachoroidal Drug Delivery Forwar...

Everads Pushes Suprachoroidal Drug Delivery Forwar...

Category : Clinical Trial Update 4 May 2026

Retinal drug delivery has a bottleneck: getting enough drug to the back of the eye without invasive...

Categories

Latest Newsletter Post

Subscribe to Our Newsletter!

Subscribe to get latest updates and information.

Welcome Back Sign in to Continue

Don't Have an Account? Sign Up!
Forgot Password?

Create your Account!